J Korean Med Sci.  2023 Sep;38(35):e277. 10.3346/jkms.2023.38.e277.

Cancer Incidence in Living Liver Donors After Donor Hepatectomy

• Kim J
• Kim JH
• Kim HJ

• KMID: 2545555
• DOI: http://doi.org/10.3346/jkms.2023.38.e277

Abstract

Living liver donors (LLDs) are screened for transmissible diseases including cancer. We investigated the actual cancer incidence of LLDs compared with a matched healthy control group from the general Korean population using data from the Korean National Health Insurance Services (NHIS). A total of 12,372 LLDs who donated a liver graft between 2002 and 2018 were registered in the Korean Network for Organ Sharing. They were compared to a matched healthy control group selected from the Korean NHIS. Cancer diagnosis was identified in 175 LLDs (1.4%) and 1,014 controls (0.8%). Compared to the healthy control group, the incidence rate ratio of liver and thyroid cancer in the LLD group were significantly higher at 18.30 and 1.39, respectively. The incidences of 11 other specified cancers were not different between the two groups. The present study suggests that LLD after donor hepatectomy may require medical surveillance, especially for liver cancer.

Keyword

Living Liver Donors; Liver Transplantation; Malignancy

Reference

1. Lee O, Kim JM, Kim SJ, Rhu J, Choi GS, Joh JW. Healthy spouses can be considered as living liver donors. World J Surg. 2022; 46(6):1474–1484. PMID: 35316397.

2. Choi JY, Kim JH, Kim JM, Kim HJ, Ahn HS, Joh JW. Outcomes of living liver donors are worse than those of matched healthy controls. J Hepatol. 2022; 76(3):628–638. PMID: 34785324.

3. Lee JG, Lee KW, Kwon CH, Chu CW, Kim BW, Choi DL, et al. Donor safety in living donor liver transplantation: the Korean organ transplantation registry study. Liver Transpl. 2017; 23(8):999–1006. PMID: 28431203.

4. Engels EA, Fraser GE, Kasiske BL, Snyder JJ, Utt J, Lynch CF, et al. Cancer risk in living kidney donors. Am J Transplant. 2022; 22(8):2006–2015. PMID: 35510728.

5. Kim JM, Kim DG, Kim J, Lee K, Lee KW, Ryu JH, et al. Outcomes after liver transplantation in Korea: incidence and risk factors from Korean transplantation registry. Clin Mol Hepatol. 2021; 27(3):451–462. PMID: 33525077.

6. Domínguez-Gil B, Moench K, Watson C, Serrano MT, Hibi T, Asencio JM, et al. Prevention and management of donor-transmitted cancer after liver transplantation: guidelines from the ILTS-SETH consensus conference. Transplantation. 2022; 106(1):e12–e29. PMID: 34905759.